Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bonora

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
The Journal of Antimicrobial Chemotherapy|October 23, 2012
Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitorsA Calcagno, M C Tettoni, M Simiele, et al.
Respiratory Medicine|April 1, 1997
Aetiology of pneumonia following isolated closed head injuryA Cazzadori, G Di Perri, S Vento, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 1997
Microsporidium species in pulmonary cavitary lesions of AIDS patients infected with Rhodococcus equiM Lanzafame, S Bonora, G Di Perri, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 1, 1996
Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patientsG Di Perri, A Cazzadori, S Vento, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 2006
Penetration of didanosine in semen of HIV-1-infected menM Cruciani, G Liuzzi, A Chirianni, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2005
Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patientsF Canta, R Marrone, S Bonora, et al.
The Journal of Antimicrobial Chemotherapy|August 10, 2000
Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluidB Allegranzi, A Cazzadori, G Di Perri, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2020
Antiretroviral concentrations in the presence and absence of valproic acidA Calcagno, J Cusato, M Ferrara, et al.
Journal of Clinical Microbiology|September 17, 1999
Comparative evaluation of ligation-mediated PCR and spoligotyping as screening methods for genotyping of Mycobacterium tuberculosis strainsS Bonora, M C Gutierrez, G Di Perri, et al.
The Pharmacogenomics Journal|October 7, 2015
Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urinesA Calcagno, J Cusato, L Marinaro, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
The Journal of Antimicrobial Chemotherapy|October 23, 2012
Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitorsA Calcagno, M C Tettoni, M Simiele, et al.
Respiratory Medicine|April 1, 1997
Aetiology of pneumonia following isolated closed head injuryA Cazzadori, G Di Perri, S Vento, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 1997
Microsporidium species in pulmonary cavitary lesions of AIDS patients infected with Rhodococcus equiM Lanzafame, S Bonora, G Di Perri, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 1, 1996
Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patientsG Di Perri, A Cazzadori, S Vento, et al.
The Journal of Antimicrobial Chemotherapy|March 25, 2006
Penetration of didanosine in semen of HIV-1-infected menM Cruciani, G Liuzzi, A Chirianni, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2005
Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patientsF Canta, R Marrone, S Bonora, et al.
The Journal of Antimicrobial Chemotherapy|August 10, 2000
Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluidB Allegranzi, A Cazzadori, G Di Perri, et al.
The Journal of Antimicrobial Chemotherapy|March 27, 2020
Antiretroviral concentrations in the presence and absence of valproic acidA Calcagno, J Cusato, M Ferrara, et al.
Journal of Clinical Microbiology|September 17, 1999
Comparative evaluation of ligation-mediated PCR and spoligotyping as screening methods for genotyping of Mycobacterium tuberculosis strainsS Bonora, M C Gutierrez, G Di Perri, et al.
The Pharmacogenomics Journal|October 7, 2015
Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urinesA Calcagno, J Cusato, L Marinaro, et al.
Pageof 11